Sentence examples for more comprehensive pathways from inspiring English sources

The coverages of biological pathways can be increased with the incorporation of more biological processes and protein members, promoting more comprehensive pathways.

Resources and tools are continuously added or expanded to offer more comprehensive pathway data sets as well as enhanced pathway data manipulation, exploration and visualization capabilities.

Although WebGestalt can perform enrichment tests for the Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways [ 33], the IPA system provides a more comprehensive pathway resource based on manual collection and curation.

This movement from single gene polymorphism to a more comprehensive pathway evaluation could undoubtedly offer a more tailored approach to chemotherapy by providing a more effective biomarker through a better understanding of the genetic and molecular basis underlying variable drug response among patients, and ultimately improve treatment outcomes.

In the current study, we have attempted to move beyond single gene polymorphisms to a more comprehensive pathway evaluation to identify genomic variants and patterns that may help predict clinical response and overall survival to platinum-based chemotherapy, thus ultimately leading to a more tailored approach to chemotherapy.

But footnotes to a DoH press release revealed that NHS tariffs had been "adjusted" by an unspecified amount "to include all elements of the more comprehensive care pathway to be provided by Netcare" and to take account of "market forces factors" in some geographical areas.

Since many genes are not or only partially annotated, network-based analysis can be more comprehensive than pathway-based analysis.

InnateDB also enhances pathway-specific networks providing a more comprehensive picture of pathway signalling than traditional pathway diagrams.

One way to enable a more comprehensive readout of pathway activity is to identify gene expression profiles that are indicative of pathway activation status.

We propose a model to provide a more comprehensive understanding of pathway-centric cancer therapies, which requires future in vitro and in vivo studies to validate the genes predicted to be affecting drug sensitivities.

This increased number of genes in turn helps provide more comprehensive input for pathway and network analysis of differential gene expression.